Hepatorenal Syndrome: Outcome of Response to Therapy and Predictors of Survival
Aim. Treatment of hepatorenal syndrome (HRS) in patients with liver cirrhosis is still challenging and characterized by a very high mortality. This study aimed to delineate treatment patterns and clinical outcomes of patients with HRS intravenously treated with terlipressin. Methods. In this retrosp...
Saved in:
Main Authors: | Jan Heidemann, Christoph Bartels, Christoph Berssenbrügge, Hartmut Schmidt, Tobias Meister |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/457613 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of hepatorenal syndrome and associated outcomes: a systematic review
by: Anahid Hamidianjahromi, et al.
Published: (2024-04-01) -
Renal Impairment in Cirrhosis Unrelated to Hepatorenal Syndrome
by: Gavin Low, et al.
Published: (2015-01-01) -
Update on Peripheral Arterial Vasodilation, Ascites and Hepatorenal Syndrome in Cirrhosis
by: Mladen Knotek, et al.
Published: (2000-01-01) -
Sindrom Hepatorenal pada Anak
by: Yusri Dianne Jurnalis, et al.
Published: (2012-11-01) -
Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?
by: Sondes Bizid, et al.
Published: (2020-01-01)